Anemia and Mild Cognitive Impairment in the German General Population

Martha Dlugaj1, Angela Winkler1, Christian Weimar1

  • 1Department of Neurology, University Hospital of Essen, University of Duisburg-Essen, Essen, Germany.

Insights

Anemia is linked to a higher risk of mild cognitive impairment (MCI), affecting memory and executive functions. Treating anemia may help reduce this risk, highlighting its clinical importance.

Area of Science:

  • Neurology
  • Hematology
  • Epidemiology

Background:

  • Growing evidence links anemia to cognitive impairment.
  • Understanding the relationship between anemia and mild cognitive impairment (MCI) is crucial for public health.
  • Anemia's impact on cognitive subtypes requires further investigation.

Purpose of the Study:

  • To investigate the association between current anemia and mild cognitive impairment (MCI).
  • To examine the link between persistent anemia over five years and MCI.
  • To explore the relationship between anemia and specific MCI subtypes: amnestic MCI (aMCI) and non-amnestic MCI (naMCI).

Main Methods:

  • Cross-sectional study analyzing data from 4,033 participants (aged 50-80) from a cohort study.
  • Anemia defined by hemoglobin levels (<13 g/dl for men, <12 g/dl for women).
  • Logistic regression models used to assess the association of anemia at baseline (t0) and follow-up (t1) with MCI, controlling for cardiovascular risk factors.

Main Results:

  • Anemic participants demonstrated poorer performance in verbal memory and executive functions.
  • Anemia was associated with an increased odds ratio for MCI (1.92), aMCI (1.96), and naMCI (1.88).
  • Anemia at both time points showed a non-significant association with naMCI (OR 3.74).

Conclusions:

  • Anemia is independently associated with an increased risk of developing MCI.
  • The findings underscore the clinical relevance of managing anemia for cognitive health.
  • Effective treatments for many anemia causes suggest potential for mitigating cognitive decline.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
702
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
836
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.2K
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
632
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
317